Espinoza J Luis, Ai Suzue, Matsumura Itaru
Department of Hematology and Rheumatology, Kindai University Faculty of Medicine, 377-2, Ohno-Higashi, Osaka-Sayama, Osaka 577-8502, Japan.
Faculty of Medicine, Kindai University, 377-2, Ohno-Higashi, Osaka-Sayama, Osaka 577-8502, Japan.
Pathogens. 2018 Sep 6;7(3):73. doi: 10.3390/pathogens7030073.
Takayasu arteritis (TAK) is a chronic vasculitis that mainly affects the aorta, its major branches, and the pulmonary arteries. Since the description of the first case by Mikito Takayasu in 1908, several aspects of this rare disease, including the epidemiology, diagnosis, and the appropriate clinical assessment, have been substantially defined. Nevertheless, while it is well-known that TAK is associated with a profound inflammatory process, possibly rooted to an autoimmune disorder, its precise etiology has remained largely unknown. Efforts to identify the antigen(s) that trigger autoimmunity in this disease have been unsuccessful, however, it is likely that viruses or bacteria, by a molecular mimicry mechanism, initiate or propagate the auto-immune process in this disease. In this article, we summarize recent advances in the understanding of TAK, with emphasis on new insights related to the pathogenesis of this entity that may contribute to the design of novel therapeutic approaches.
高安动脉炎(TAK)是一种主要累及主动脉、其主要分支及肺动脉的慢性血管炎。自1908年高安道夫首次描述首例病例以来,这种罕见疾病的几个方面,包括流行病学、诊断及适当的临床评估,已得到充分界定。然而,尽管众所周知TAK与一个可能源于自身免疫性疾病的深刻炎症过程相关,但其确切病因在很大程度上仍不清楚。在本病中识别引发自身免疫的抗原的努力尚未成功,不过,病毒或细菌很可能通过分子模拟机制启动或传播本病的自身免疫过程。在本文中,我们总结了对TAK认识的最新进展,重点是与该疾病发病机制相关的新见解,这些见解可能有助于设计新的治疗方法。